FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Erlend Smeland

Research Profile

Anatomy

Physiology

Disorders

Lymphoma, B-Cell

Chemicals & Drugs

Procedures

Co-author Network

Publications

TOP 3
Morten P Oksvold; Nina Marie Pedersen; Lise Forfang; Erlend Smeland
Effect of cycloheximide on epidermal growth factor receptor trafficking and signaling.
Olav E Yri; Knut Liestøl; Erlend Smeland; Per O Ekstrøm; Gustav Gaudernack; Vera Hilden; Harald Holte
Polymorphisms in genes encoding interleukin-10 and drug metabolizing enzymes GSTP1, GSTT1, GSTA1 and UGT1A1 influence risk and outcome in Hodgkin lymphoma.
Maren Bakkebø; Lise Forfang; Vera I Hilden; Kanutte Huse; June H Myklebust; Erlend Smeland; Morten P Oksvold
SARA is dispensable for functional TGF-β signaling.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Erlend Smeland (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Morten P Oksvold; Nina Marie Pedersen; Lise Forfang; Erlend Smeland
Effect of cycloheximide on epidermal growth factor receptor trafficking and signaling.
FEBS letters 2012;586(20):3575-81.
2012: Olav E Yri; Knut Liestøl; Erlend Smeland; Per O Ekstrøm; Gustav Gaudernack; Vera Hilden; Harald Holte
Polymorphisms in genes encoding interleukin-10 and drug metabolizing enzymes GSTP1, GSTT1, GSTA1 and UGT1A1 influence risk and outcome in Hodgkin lymphoma.
Leukemia & lymphoma 2012;53(10):1934-44.
2012: Maren Bakkebø; Lise Forfang; Vera I Hilden; Kanutte Huse; June H Myklebust; Erlend Smeland; Morten P Oksvold
SARA is dispensable for functional TGF-β signaling.
FEBS letters 2012;586(19):3367-72.
2012: Kanutte Huse; Knut Liestøl; Morten P Oksvold; Erlend Smeland; Sébastien Wälchli; Ash A Alizadeh; Maren Bakkebø; May L Bredahl; Lise Forfang; Vera I Hilden; June H Myklebust
Role of Smad proteins in resistance to BMP-induced growth inhibition in B-cell lymphoma.
PloS one 2012;7(10):e46117.
2012: Björn E Wahlin; Olav E Yri; Erlend Smeland; Christer Sundström; Birger Christensson; Jan Delabie; Harald Holte; Eva Kimby; Birgitta Sander
Clinical significance of the WHO grades of follicular lymphoma in a population-based cohort of 505 patients with long follow-up times.
British journal of haematology 2012;156(2):225-33.
2011: D Josefsen; Anne Kirsti Blystad; Marianne Dyrhaug; Lise Forfang; Erlend Smeland; Trond Stokke; Gunnar Kvalheim
Side population cells in highly enriched CD34-positive cells from peripheral blood progenitor cells identify an immature subtype of hematopoietic progenitor cells but do not predict time to engraftment in patients treated with high-dose therapy.
European journal of haematology 2011;87(6):494-502.
2011: Kanutte Huse; Maren Bakkebø; Lise Forfang; Vera I Hilden; Morten P Oksvold; Erlend Smeland; Trond Stokke; June H Myklebust
Bone morphogenetic proteins inhibit CD40L/IL-21-induced Ig production in human B cells: differential effects of BMP-6 and BMP-7.
European journal of immunology 2011;41(11):3135-45.
2011: Raquel Malumbres; Xabier Agirre; Giovanna G Altobelli; Maria Angela Aznar; Miriam Bobadilla; María J Calasanz; Vicente Fresquet; Izidore S Lossos; Vanesa Martin-Palanco; Felipe Prosper; Eloy Francisco Robles; Jose Roman-Gomez; Erlend Smeland; Jose A Martinez-Climent
LMO2 expression reflects the different stages of blast maturation and genetic features in B-cell acute lymphoblastic leukemia and predicts clinical outcome.
Haematologica 2011;96(7):980-6.
2010: Marianne Brodtkorb Eide; Knut Liestøl; Ole Christian Lingjaerde; Marit E Hystad; Stine H Kresse; Leonardo A. Meza-Zepeda; Ola Myklebost; Gunhild Trøen; Hege Vangstein Aamot; Harald Holte; Erlend Smeland; Jan Delabie
Genomic alterations reveal potential for higher grade transformation in follicular lymphoma and confirm parallel evolution of tumor cell clones.
Blood 2010;116(9):1489-97.
2010: Maren Bakkebø; Kanutte Huse; Vera I Hilden; Erlend Smeland; Morten P Oksvold
TGF-β-induced growth inhibition in B-cell lymphoma correlates with Smad1/5 signalling and constitutively active p38 MAPK.
BMC immunology 2010;11():57.
2009: C O'Riain; D M O'Shea; Y Yang; R Le Dieu; John G Gribben; K Summers; J Yeboah-Afari; L Bhaw-Rosun; C Fleischmann; Charles A Mein; T Crook; P Smith; G Kelly; A Rosenwald; G Ott; E Campo; Lisa M Rimsza; Erlend Smeland; Wing C Chan; N Johnson; Randy D Gascoyne; S Reimer; Rita M Braziel; G W Wright; L M Staudt; T Andrew Lister; Jude Fitzgibbon
Array-based DNA methylation profiling in follicular lymphoma.
Leukemia 2009;23(10):1858-66.
2008: G Lenz; G Wright; S S Dave; W Xiao; J Powell; H Zhao; W Xu; B Tan; N Goldschmidt; J Iqbal; J Vose; M Bast; K Fu; D D Weisenburger; T C Greiner; J O Armitage; A Kyle; L May; R D Gascoyne; Joseph Michael Connors; G Troen; H Holte; S Kvaloy; D Dierickx; G Verhoef; J Delabie; Erlend Smeland; P Jares; A Martinez; A Lopez-Guillermo; E Montserrat; E Campo; Rita M Braziel; T P Miller; Lisa M Rimsza; J R Cook; B Pohlman; J Sweetenham; R R Tubbs; Richard I Fisher; E Hartmann; A Rosenwald; G Ott; H-K Muller-Hermelink; D Wrench; T A Lister; E S Jaffe; W H Wilson; W C Chan; L M Staudt
Stromal gene signatures in large-B-cell lymphomas.
The New England journal of medicine 2008;359(22):2313-23.
2008: Derville O'Shea; Ciarán O'Riain; Claire Taylor; Rachel Waters; Emanuela Carlotti; Finlay Macdougall; John Gribben; Andreas Rosenwald; German Ott; Lisa M Rimsza; Erlend Smeland; Nathalie Johnson; Elias Campo; Timothy C Greiner; Wing C Chan; Randy D Gascoyne; George Wright; Louis M Staudt; T Andrew Lister; Jude Fitzgibbon
The presence of TP53 mutation at diagnosis of follicular lymphoma identifies a high-risk group of patients with shortened time to disease progression and poorer overall survival.
Blood 2008;112(8):3126-9.
2008: Georg Lenz; George W Wright; N C Tolga Emre; Holger Kohlhammer; Sandeep S Dave; R Eric Davis; Shannon Carty; Lloyd T Lam; A L Shaffer; Wenming Xiao; John Powell; Andreas Rosenwald; German Ott; Hans Konrad Muller-Hermelink; Randy D Gascoyne; Joseph Michael Connors; Elias Campo; Elaine S Jaffe; Jan Delabie; Erlend Smeland; Lisa M Rimsza; Richard I Fisher; Dennis D Weisenburger; Wing C Chan; Louis M Staudt
Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways.
Proceedings of the National Academy of Sciences of the United States of America 2008;105(36):13520-5.
2008: Georg Lenz; R Eric Davis; Vu N Ngo; Lloyd Lam; Thaddeus C George; George W Wright; Sandeep Dave; Hong Zhao; Weihong Xu; Andreas Rosenwald; German Ott; Hans Konrad Muller-Hermelink; Randy D Gascoyne; Joseph Michael Connors; Lisa M Rimsza; Elias Campo; Elaine S Jaffe; Jan Delabie; Erlend Smeland; Richard I Fisher; Wing C Chan; Louis M Staudt
Oncogenic CARD11 mutations in human diffuse large B cell lymphoma.
Science (New York, N.Y.) 2008;319(5870):1676-9.
2007: Einar A Sivertsen; Kanutte Huse; Marit E Hystad; Christian Kersten; Erlend Smeland; June H Myklebust
Inhibitory effects and target genes of bone morphogenetic protein 6 in Jurkat TAg cells.
European journal of immunology 2007;37(10):2937-48.
2007: Marit E Hystad; June H Myklebust; Trond Hellem Bø; Einar A Sivertsen; Edith Rian; Lise Forfang; Else Munthe; Andreas Rosenwald; Michael Chiorazzi; Inge Jonassen; Louis M Staudt; Erlend Smeland
Characterization of early stages of human B cell development by gene expression profiling.
Journal of immunology (Baltimore, Md. : 1950) 2007;179(6):3662-71.
2007: Adrian Wiestner; Mahsa Tehrani; Michael Chiorazzi; George Wright; Federica Gibellini; Kazutaka Nakayama; Hui Liu; Andreas Rosenwald; H Konrad Muller-Hermelink; German Ott; Wing C Chan; Timothy C Greiner; Dennis D Weisenburger; Julie M Vose; James O Armitage; Randy D Gascoyne; Joseph Michael Connors; Elias Campo; Emili Montserrat; Francesc Bosch; Erlend Smeland; Stein Kvaloy; Harald Holte; Jan Delabie; Richard I Fisher; Thomas M Grogan; Thomas P Miller; Wyndham H Wilson; Elaine S Jaffe; Louis M Staudt
Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survival.
Blood 2007;109(11):4599-606.
2007: Georg Lenz; Inga Nagel; Reiner Siebert; Anna V Roschke; Warren Sanger; George W Wright; Sandeep S Dave; Bruce Tan; Hong Zhao; Andreas Rosenwald; H Konrad Muller-Hermelink; Randy D Gascoyne; Elias Campo; Elaine S Jaffe; Erlend Smeland; Richard I Fisher; W Michael Kuehl; Wing C Chan; Louis M Staudt
Aberrant immunoglobulin class switch recombination and switch translocations in activated B cell-like diffuse large B cell lymphoma.
The Journal of experimental medicine 2007;204(3):633-43.
2006: Einar A Sivertsen; Marit E Hystad; Kristine B Gutzkow; Guri Døsen; Erlend Smeland; Heidi Kiil Blomhoff; June H Myklebust
PI3K/Akt-dependent Epo-induced signalling and target genes in human early erythroid progenitor cells.
British journal of haematology 2006;135(1):117-28.
2006: Sandeep S Dave; Kai Fu; George W Wright; Lloyd T Lam; Philip Kluin; Evert-Jan Boerma; Timothy C Greiner; Dennis D Weisenburger; Andreas Rosenwald; German Ott; Hans-Konrad Müller-Hermelink; Randy D Gascoyne; Jan Delabie; Lisa M Rimsza; Rita M Braziel; Thomas M Grogan; Elias Campo; Elaine S Jaffe; Bhavana J Dave; Warren Sanger; Martin Bast; Julie M Vose; James O Armitage; Joseph Michael Connors; Erlend Smeland; Stein Kvaloy; Harald Holte; Richard I Fisher; Thomas P Miller; Emilio Montserrat; Wyndham H Wilson; Manisha Bahl; Hong Zhao; Liming Yang; John Powell; Richard Simon; Wing C Chan; Louis M Staudt
Molecular diagnosis of Burkitt's lymphoma.
The New England journal of medicine 2006;354(23):2431-42.
2006: Einar A Sivertsen; Eivind Galteland; D Mu; Harald Holte; Leonardo A. Meza-Zepeda; Ola Myklebost; Sebastian Patzke; Erlend Smeland; Trond Stokke
Gain of chromosome 6p is an infrequent cause of increased PIM1 expression in B-cell non-Hodgkin's lymphomas.
Leukemia 2006;20(3):539-42.
2006: Christian Kersten; Guri Dosen; June H Myklebust; Einar A Sivertsen; Marit E Hystad; Erlend Smeland; Edith Rian
BMP-6 inhibits human bone marrow B lymphopoiesis--upregulation of Id1 and Id3.
Experimental hematology 2006;34(1):72-81.
2005: Silvia Bea; Andreas Zettl; George Wright; Itziar Salaverria; Philipp Jehn; Victor Moreno; Christof Burek; German Ott; Xavier Puig; Liming Yang; Armando Lopez-Guillermo; Wing C Chan; Timothy C Greiner; Dennis D Weisenburger; James O Armitage; Randy D Gascoyne; Joseph Michael Connors; Thomas M Grogan; Rita M Braziel; Richard I Fisher; Erlend Smeland; Stein Kvaloy; Harald Holte; Jan Delabie; Richard Simon; John Powell; Wyndham H Wilson; Elaine S Jaffe; Emili Montserrat; Hans-Konrad Muller-Hermelink; Louis M Staudt; Elias Campo; Andreas Rosenwald
Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction.
Blood 2005;106(9):3183-90.
2005: Emina Torlakovic; Agnieszka Malecka; June H Myklebust; Anne Tierens; Hans-Christian Aasheim; Jahn M Nesland; Erlend Smeland; Stein Kvaløy; Jan Delabie
PU.1 protein expression has a positive linear association with protein expression of germinal centre B cell genes including BCL-6, CD10, CD20 and CD22: identification of PU.1 putative binding sites in the BCL-6 promotor.
The Journal of pathology 2005;206(3):312-9.
2005: Christian Kersten; Einar A Sivertsen; Marit E Hystad; Lise Forfang; Erlend Smeland; June H Myklebust
BMP-6 inhibits growth of mature human B cells; induction of Smad phosphorylation and upregulation of Id1.
BMC immunology 2005;6():9.
2004: Christian Kersten; Jan Delabie; Gustav Gaudernack; Erlend Smeland; Alexander Fosså
Analysis of the autoantibody repertoire in Burkitt's lymphoma patients: frequent response against the transcription factor ATF-2.
Cancer immunology, immunotherapy : CII 2004;53(12):1119-26.
2004: Sandeep S Dave; George Wright; Bruce Tan; Andreas Rosenwald; Randy D Gascoyne; Wing C Chan; Richard I Fisher; Rita M Braziel; Lisa M Rimsza; Thomas M Grogan; Thomas P Miller; Michael LeBlanc; Timothy C Greiner; Dennis D Weisenburger; James C Lynch; Julie Vose; James O Armitage; Erlend Smeland; Stein Kvaloy; Harald Holte; Jan Delabie; Joseph Michael Connors; Peter M Lansdorp; Qin Ouyang; T Andrew Lister; Andrew J Davies; Andrew J Norton; H Konrad Muller-Hermelink; German Ott; Elias Campo; Emilio Montserrat; Wyndham H Wilson; Elaine S Jaffe; Richard Simon; Liming Yang; John Powell; Hong Zhao; Neta Goldschmidt; Michael Chiorazzi; Louis M Staudt
Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells.
The New England journal of medicine 2004;351(21):2159-69.
2004: Alexander Fosså; Aasmund Berner; Sophie D Fosså; Eivor Hernes; Gustav Gaudernack; Erlend Smeland
NY-ESO-1 protein expression and humoral immune responses in prostate cancer.
The Prostate 2004;59(4):440-7.
2004: Alexander Fosså; Lene Alsøe; Reto Crameri; Steinar Funderud; Gustav Gaudernack; Erlend Smeland
Serological cloning of cancer/testis antigens expressed in prostate cancer using cDNA phage surface display.
Cancer immunology, immunotherapy : CII 2004;53(5):431-8.
2003: Andreas Rosenwald; George Wright; Karen Leroy; Xin Yu; Philippe Gaulard; Randy D Gascoyne; Wing C Chan; Tong Zhao; Corinne Haioun; Timothy C Greiner; Dennis D Weisenburger; James C Lynch; Julie Vose; James O Armitage; Erlend Smeland; Stein Kvaloy; Harald Holte; Jan Delabie; Elias Campo; Emili Montserrat; Armando Lopez-Guillermo; German Ott; H Konrad Muller-Hermelink; Joseph Michael Connors; Rita M Braziel; Thomas M Grogan; Richard I Fisher; Thomas P Miller; Michael LeBlanc; Michael Chiorazzi; Hong Zhao; Liming Yang; John Powell; Wyndham H Wilson; Elaine S Jaffe; Richard Simon; Richard D Klausner; Louis M Staudt
Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma.
The Journal of experimental medicine 2003;198(6):851-62.
2003: Andreas Rosenwald; George Wright; Adrian Wiestner; Wing C Chan; Joseph Michael Connors; Elias Campo; Randy D Gascoyne; Thomas M Grogan; H Konrad Muller-Hermelink; Erlend Smeland; Michael Chiorazzi; Jennifer Giltnane; Elaine M Hurt; Hong Zhao; Lauren Averett; Sarah Henrickson; Liming Yang; John Powell; Wyndham H Wilson; Elaine S Jaffe; Richard Simon; Richard D Klausner; Emilio Montserrat; Francesc Bosch; Timothy C Greiner; Dennis D Weisenburger; Warren G Sanger; Bhavana J Dave; James C Lynch; Julie Vose; James O Armitage; Richard I Fisher; Thomas P Miller; Michael LeBlanc; German Ott; Stein Kvaloy; Harald Holte; Jan Delabie; Louis M Staudt
The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma.
Cancer cell 2003;3(2):185-97.
2002: Junbai Wang; Jan Delabie; Hans-Christian Aasheim; Erlend Smeland; Ola Myklebost
Clustering of the SOM easily reveals distinct gene expression patterns: results of a reanalysis of lymphoma study.
BMC bioinformatics 2002;3():36.
2002: June H Myklebust; Heidi Kiil Blomhoff; Leiv Sindre Rusten; Trond Stokke; Erlend Smeland
Activation of phosphatidylinositol 3-kinase is important for erythropoietin-induced erythropoiesis from CD34(+) hematopoietic progenitor cells.
Experimental hematology 2002;30(9):990-1000.
2002: Andreas Rosenwald; George Wright; Wing C Chan; Joseph Michael Connors; Elias Campo; Richard I Fisher; Randy D Gascoyne; H Konrad Muller-Hermelink; Erlend Smeland; Jennifer Giltnane; Elaine M Hurt; Hong Zhao; Lauren Averett; Liming Yang; Wyndham H Wilson; Elaine S Jaffe; Richard Simon; Richard D Klausner; John Powell; Patricia L Duffey; Dan Longo; Timothy C Greiner; Dennis D Weisenburger; Warren G Sanger; Bhavana J Dave; James C Lynch; Julie Vose; James O Armitage; Emilio Montserrat; Armando López-Guillermo; Thomas M Grogan; Thomas P Miller; Michel LeBlanc; German Ott; Stein Kvaloy; Jan Delabie; Harald Holte; Peter Krajci; Trond Stokke; Louis M Staudt
The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma.
The New England journal of medicine 2002;346(25):1937-47.
2001: Trond Stokke; Paula M DeAngelis; L Smedshammer; Eivind Galteland; Harald B Steen; Erlend Smeland; Jan Delabie; Harald Holte
Loss of chromosome 11q21-23.1 and 17p and gain of chromosome 6p are independent prognostic indicators in B-cell non-Hodgkin's lymphoma.
British journal of cancer 2001;85(12):1900-13.
2001: Anne Kirsti Blystad; Harald Holte; Stein Kvaløy; Erlend Smeland; Jan Delabie; Gunnar Kvalheim
High-dose therapy in patients with Hodgkin's disease: the use of selected CD34(+) cells is as safe as unmanipulated peripheral blood progenitor cells.
Bone marrow transplantation 2001;28(9):849-57.
2001: Eivind Hovig; Ola Myklebost; S Aamdal; Erlend Smeland
[Gene therapy in cancer].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 2001;121(4):482-8.
2001: A Lyngstadaas; Erlend Smeland
[Gene therapy--status and recommendations in Norwegian health care system].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 2001;121(3):343-8.
2000: Alexander Fosså; R Siebert; Hans-Christian Aasheim; Gunhild M Maelandsmo; Aasmund Berner; Sophie D Fosså; Elisabeth Paus; Erlend Smeland; Gustav Gaudernack
Identification of nucleolar protein No55 as a tumour-associated autoantigen in patients with prostate cancer.
British journal of cancer 2000;83(6):743-9.
2000: Trond Stokke; Eivind Galteland; Harald Holte; L Smedshammer; Z Suo; Erlend Smeland; Anne-Lise Børresen-Dale; Paula M DeAngelis; Harald B Steen
Oncogenic aberrations in the p53 pathway are associated with a high S phase fraction and poor patient survival in B-cell Non-Hodgkin's lymphoma.
International journal of cancer. Journal international du cancer 2000;89(4):313-24.
2000: Soheil Naderi; Kristine Bjerve Gützkow; J Christoffersen; Erlend Smeland; Heidi Kiil Blomhoff
cAMP-mediated growth inhibition of lymphoid cells in G1: rapid down-regulation of cyclin D3 at the level of translation.
European journal of immunology 2000;30(6):1757-68.
2000: June H Myklebust; Erlend Smeland; D Josefsen; Mouldy Sioud
Protein kinase C-alpha isoform is involved in erythropoietin-induced erythroid differentiation of CD34(+) progenitor cells from human bone marrow.
Blood 2000;95(2):510-8.
2000: D Josefsen; June H Myklebust; J Lømo; Mouldy Sioud; Heidi Kiil Blomhoff; Erlend Smeland
Differential expression of bcl-2 homologs in human CD34(+) hematopoietic progenitor cells induced to differentiate into erythroid or granulocytic cells.
Stem cells (Dayton, Ohio) 2000;18(4):261-72.
2000: Hans-Christian Aasheim; Else Munthe; Steinar Funderud; Erlend Smeland; K Beiske; Ton Logtenberg
A splice variant of human ephrin-A4 encodes a soluble molecule that is secreted by activated human B lymphocytes.
Blood 2000;95(1):221-30.
1999: B Davidson; Björn Risberg; Aasmund Berner; Erlend Smeland; Emina Torlakovic
Evaluation of lymphoid cell populations in cytology specimens using flow cytometry and polymerase chain reaction.
Diagnostic molecular pathology : the American journal of surgical pathology, part B 1999;8(4):183-8.
1999: Soheil Naderi; Rune Blomhoff; June H Myklebust; Erlend Smeland; Bjørn Erikstein; Kaare R Norum; Heidi Kiil Blomhoff
Lovastatin inhibits G1/S transition of normal human B-lymphocytes independent of apoptosis.
Experimental cell research 1999;252(1):144-53.
1999: D Josefsen; June H Myklebust; D H Lynch; Trond Stokke; Heidi Kiil Blomhoff; Erlend Smeland
Fas ligand promotes cell survival of immature human bone marrow CD34+CD38- hematopoietic progenitor cells by suppressing apoptosis.
Experimental hematology 1999;27(9):1451-9.
1999: June H Myklebust; D Josefsen; Heidi Kiil Blomhoff; Finn Olav Levy; Soheil Naderi; J C Reed; Erlend Smeland
Activation of the cAMP signaling pathway increases apoptosis in human B-precursor cells and is associated with downregulation of Mcl-1 expression.
Journal of cellular physiology 1999;180(1):71-80.
1999: D Josefsen; Heidi Kiil Blomhoff; J Lømo; Anne Kirsti Blystad; Erlend Smeland
Retinoic acid induces apoptosis of human CD34+ hematopoietic progenitor cells: involvement of retinoic acid receptors and retinoid X receptors depends on lineage commitment of the hematopoietic progenitor cells.
Experimental hematology 1999;27(4):642-53.
1999: Harald Holte; Z Suo; Erlend Smeland; Stein Kvaløy; Ruth Langholm; T Stokke
Prognostic value of lymphoma-specific S-phase fraction compared with that of other cell proliferation markers.
Acta oncologica (Stockholm, Sweden) 1999;38(4):495-503.
1998: S Heim; Erlend Smeland
[Molecular genetic diagnosis of leukemias and lymphomas].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 1998;118(16):2511-8.
1998: Trond Stokke; Erlend Smeland; Stein Kvaløy; Harald Holte
Tumour cell proliferation, but not apoptosis, predicts survival in B-cell non-Hodgkin's lymphomas.
British journal of cancer 1998;77(11):1839-41.
1998: Trond Stokke; Harald Holte; L Smedshammer; Erlend Smeland; Olav Kaalhus; Harald B Steen
Proliferation and apoptosis in malignant and normal cells in B-cell non-Hodgkin's lymphomas.
British journal of cancer 1998;77(11):1832-8.
1998: Ellen Aurlien; Harald Holte; A Pharo; Stein Kvaløy; Erling Jakobsen; Erlend Smeland; Gunnar Kvalheim
Combination chemotherapy with mitoguazon, ifosfamide, MTX, etoposide (MIME) and G-CSF can efficiently mobilize PBPC in patients with Hodgkin's and non-Hodgkin's lymphoma.
Bone marrow transplantation 1998;21(9):873-8.
1998: J Lømo; Erlend Smeland; Stine M Ulven; V Natarajan; Rune Blomhoff; U Gandhi; M I Dawson; Heidi Kiil Blomhoff
RAR-, not RXR, ligands inhibit cell activation and prevent apoptosis in B-lymphocytes.
Journal of cellular physiology 1998;175(1):68-77.
1998: B Ly; Jens Hammerstrøm; J Bergheim; Inger Marie S Dahl; KA Grøttum; Bottolf Lødemel; K Baklien; Erlend Smeland
[Chronic lymphatic leukemia. Immunophenotyping as an aid to correct diagnosis].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 1998;118(2):233-7.
1997: A M Rasmussen; Václav Horejsí; Finn Olav Levy; Heidi Kiil Blomhoff; Erlend Smeland; K Beiske; T E Michaelsen; Gustav Gaudernack; Steinar Funderud
CDw78--a determinant on a major histocompatibility complex class II subpopulation that can be induced to associate with the cytoskeleton.
European journal of immunology 1997;27(12):3206-13.
1997: E Hallan; Heidi Kiil Blomhoff; Erlend Smeland; J Lømo
Involvement of ICE (Caspase) family in gamma-radiation-induced apoptosis of normal B lymphocytes.
Scandinavian journal of immunology 1997;46(6):601-8.
1997: Erlend Smeland
[Changing physician's role].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 1997;117(29):4290.
1997: J Lømo; Heidi Kiil Blomhoff; S E Jacobsen; S Krajewski; J C Reed; Erlend Smeland
Interleukin-13 in combination with CD40 ligand potently inhibits apoptosis in human B lymphocytes: upregulation of Bcl-xL and Mcl-1.
Blood 1997;89(12):4415-24.
1997: A M Kvingedal; Erlend Smeland
A novel putative G-protein-coupled receptor expressed in lung, heart and lymphoid tissue.
FEBS letters 1997;407(1):59-62.
1997: Hans-Christian Aasheim; Florence Pedeutour; Erlend Smeland
Characterization, expression and chromosomal localization of a human gene homologous to the mouse Lsc oncogene, with strongest expression in hematopoetic tissues.
Oncogene 1997;14(14):1747-52.
1996: Gunnar Kvalheim; A Pharo; Harald Holte; E Jakobsen; Bjørn Erikstein; Stein Kvaløy; K Beiske; J M Nesland; Erlend Smeland
[High-dose therapy of cancer with CD34 positive cells as stem cell support].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 1996;116(21):2542-6.
1996: Gunnar Kvalheim; M Y Wang; A Pharo; Harald Holte; E Jacobsen; K Beiske; Stein Kvaløy; Erlend Smeland; Steinar Funderud; Oystein Fodstad
Purging of tumor cells from leukapheresis products: experimental and clinical aspects.
Journal of hematotherapy 1996;5(4):427-36.
1996: Oystein Røsok; Jacob Odeberg; M Rode; T Stokke; Steinar Funderud; Erlend Smeland; Joakim Lundeberg
Solid-phase method for differential display of genes expressed in hematopoietic stem cells.
BioTechniques 1996;21(1):114-21.
1996: Finn Olav Levy; A M Rasmussen; Kjetil Taskén; Bjørn S Skålhegg; Henrik S Huitfeldt; Steinar Funderud; Erlend Smeland; V Hansson
Cyclic AMP-dependent protein kinase (cAK) in human B cells: co-localization of type I cAK (RI alpha 2 C2) with the antigen receptor during anti-immunoglobulin-induced B cell activation.
European journal of immunology 1996;26(6):1290-6.
1996: L S Rusten; I Dybedal; Heidi Kiil Blomhoff; Rune Blomhoff; Erlend Smeland; Sten Eirik W Jacobsen
The RAR-RXR as well as the RXR-RXR pathway is involved in signaling growth inhibition of human CD34+ erythroid progenitor cells.
Blood 1996;87(5):1728-36.
1996: J Lømo; Erlend Smeland; S Krajewski; J C Reed; Heidi Kiil Blomhoff
Expression of the Bcl-2 homologue Mcl-1 correlates with survival of peripheral blood B lymphocytes.
Cancer research 1996;56(1):40-3.
1995: C Fahlman; Sten Eirik W Jacobsen; Erlend Smeland; J Lømo; C E Naess; Steinar Funderud; Heidi Kiil Blomhoff
All-trans- and 9-cis-retinoic acid inhibit growth of normal human and murine B cell precursors.
Journal of immunology (Baltimore, Md. : 1950) 1995;155(1):58-65.
1995: A H Deggerdal; F Pettersen; Gunnar Kvalheim; E Hornes; Erlend Smeland; Oystein Fodstad; Eivind Hovig
Semiquantitative polymerase chain reaction for t(14;18) in follicular lymphomas: a colorimetric approach.
Laboratory investigation; a journal of technical methods and pathology 1995;72(4):411-8.
1995: D A Aas-Eng; H C Asheim; A Deggerdal; Erlend Smeland; Steinar Funderud
Characterization of a promoter region supporting transcription of a novel human beta-galactoside alpha-2,6-sialyltransferase transcript in HepG2 cells.
Biochimica et biophysica acta 1995;1261(1):166-9.
1995: J Lømo; Heidi Kiil Blomhoff; K Beiske; Trond Stokke; Erlend Smeland
TGF-beta 1 and cyclic AMP promote apoptosis in resting human B lymphocytes.
Journal of immunology (Baltimore, Md. : 1950) 1995;154(4):1634-43.
1994: A M Rasmussen; Heidi Kiil Blomhoff; Trond Stokke; V Horejsi; Erlend Smeland
Cross-linking of CD53 promotes activation of resting human B lymphocytes.
Journal of immunology (Baltimore, Md. : 1950) 1994;153(11):4997-5007.
1994: Erlend Smeland; L Rusten; Sten Eirik W Jacobsen; B Skrede; Rune Blomhoff; M Y Wang; Steinar Funderud; Gunnar Kvalheim; Heidi Kiil Blomhoff
All-trans retinoic acid directly inhibits granulocyte colony-stimulating factor-induced proliferation of CD34+ human hematopoietic progenitor cells.
Blood 1994;84(9):2940-5.
1994: F W Jacobsen; M Rothe; L Rusten; D V Goeddel; Erlend Smeland; O P Veiby; L Slørdal; Sten Eirik W Jacobsen
Role of the 75-kDa tumor necrosis factor receptor: inhibition of early hematopoiesis.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(22):10695-9.
1994: L S Rusten; Sten Eirik W Jacobsen; O Kaalhus; O P Veiby; Steinar Funderud; Erlend Smeland
Functional differences between CD38- and DR- subfractions of CD34+ bone marrow cells.
Blood 1994;84(5):1473-81.
1994: L S Rusten; Erlend Smeland; F W Jacobsen; E Lien; W Lesslauer; Hansruedi Loetscher; C M Dubois; Sten Eirik W Jacobsen
Tumor necrosis factor-alpha inhibits stem cell factor-induced proliferation of human bone marrow progenitor cells in vitro. Role of p55 and p75 tumor necrosis factor receptors.
The Journal of clinical investigation 1994;94(1):165-72.
1994: L S Rusten; F W Jacobsen; W Lesslauer; Hansruedi Loetscher; Erlend Smeland; Sten Eirik W Jacobsen
Bifunctional effects of tumor necrosis factor alpha (TNF alpha) on the growth of mature and primitive human hematopoietic progenitor cells: involvement of p55 and p75 TNF receptors.
Blood 1994;83(11):3152-9.
1994: Sten Eirik W Jacobsen; C Fahlman; Heidi Kiil Blomhoff; C Okkenhaug; L S Rusten; Erlend Smeland
All-trans- and 9-cis-retinoic acid: potent direct inhibitors of primitive murine hematopoietic progenitors in vitro.
The Journal of experimental medicine 1994;179(5):1665-70.
1994: J Christoffersen; Erlend Smeland; Trond Stokke; Kjetil Taskén; Kristin B Andersson; Heidi Kiil Blomhoff
Retinoblastoma protein is rapidly dephosphorylated by elevated cyclic adenosine monophosphate levels in human B-lymphoid cells.
Cancer research 1994;54(8):2245-50.
1994: Hans-Christian Aasheim; A Deggerdal; Erlend Smeland; E Hornes
A simple subtraction method for the isolation of cell-specific genes using magnetic monodisperse polymer particles.
BioTechniques 1994;16(4):716-21.
1994: Hans-Christian Aasheim; T Loukianova; A Deggerdal; Erlend Smeland
Tissue specific expression and cDNA structure of a human transcript encoding a nucleic acid binding [oligo(dC)] protein related to the pre-mRNA binding protein K.
Nucleic acids research 1994;22(6):959-64.
1994: Stein Kvaløy; Erlend Smeland
[Bone marrow transplantation--a constantly developing procedure--requiring updating].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 1994;114(3):302-3.
1994: Gunnar Kvalheim; E Jakobsen; Harald Holte; K Beiske; Ruth Langholm; A Høiby; M Y Wang; S Funderund; Oystein Fodstad; Erlend Smeland
Autologous bone marrow transplantation of non-Hodgkin's lymphoma patients with marrow purged using immunomagnetic beads.
Progress in clinical and biological research 1994;389():133-8.
1993: Kristin B Andersson; A Deggerdal; C Skjønsberg; Erlend Smeland; Heidi Kiil Blomhoff
Constitutive expression of c-myc does not relieve cAMP-mediated growth arrest in human lymphoid Reh cells.
Journal of cellular physiology 1993;157(1):61-9.
1993: Sten Eirik W Jacobsen; O P Veiby; Erlend Smeland
Cytotoxic lymphocyte maturation factor (interleukin 12) is a synergistic growth factor for hematopoietic stem cells.
The Journal of experimental medicine 1993;178(2):413-8.
1993: Hans-Christian Aasheim; D A Aas-Eng; A Deggerdal; Heidi Kiil Blomhoff; Steinar Funderud; Erlend Smeland
Cell-specific expression of human beta-galactoside alpha 2,6-sialyltransferase transcripts differing in the 5' untranslated region.
European journal of biochemistry / FEBS 1993;213(1):467-75.
1993: Bjørn Erikstein; Harald Holte; Stein Kvaløy; Kristin B Andersson; Harald B Steen; Einar Hannisdal; Erlend Smeland
Expression of CD18 (integrin beta 2 chain) correlates with prognosis in malignant B cell lymphomas.
British journal of haematology 1993;83(3):392-8.
1993: S H Slørdahl; Erlend Smeland; H Holte; M Grønn; S O Lie; M Seip
Leukemic blasts with markers of four cell lineages in Down's syndrome ("megakaryoblastic leukemia").
Medical and pediatric oncology 1993;21(4):254-8.
1992: Heidi Kiil Blomhoff; Erlend Smeland; Bjørn Erikstein; A M Rasmussen; B Skrede; C Skjønsberg; Rune Blomhoff
Vitamin A is a key regulator for cell growth, cytokine production, and differentiation in normal B cells.
The Journal of biological chemistry 1992;267(33):23988-92.
1992: Erlend Smeland; L Slørdal
[Cytokines--from research to clinical use].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 1992;112(28):3544.
1992: Erlend Smeland; S Funderud
[Sugar molecules, cell adhesion and cancer etiology].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 1992;112(22):2834.
1992: Trond Stokke; Harald Holte; Erlend Smeland; S O Lie; Harald B Steen
Differential chromatin structure-dependent binding of 7-aminoactinomycin D in normal and malignant bone marrow hematopoietic cells.
Cancer research 1992;52(18):5007-12.
1992: Erlend Smeland; K Beiske
[Immunophenotyping of leukemias].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 1992;112(18):2373-4.
1992: Erlend Smeland; Steinar Funderud; Gunnar Kvalheim; Gustav Gaudernack; A M Rasmussen; L Rusten; M Y Wang; R W Tindle; Heidi Kiil Blomhoff; T Egeland
Isolation and characterization of human hematopoietic progenitor cells: an effective method for positive selection of CD34+ cells.
Leukemia 1992;6(8):845-52.
1992: Erlend Smeland
[Programmed cell death--significance for cancer etiology and treatment].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 1992;112(12):1567.
1992: Bjørn Erikstein; Steinar Funderud; K Beiske; A Aas-Eng; C De Lange Davies; Heidi Kiil Blomhoff; Erlend Smeland
Cell cycle-dependent regulation of CDw75 (beta-galactoside alpha-2,6-sialyltransferase) on human B lymphocytes.
European journal of immunology 1992;22(5):1149-55.
1992: A M Rasmussen; Erlend Smeland; Bjørn Erikstein; L Caignault; Steinar Funderud
A new method for detachment of Dynabeads from positively selected B lymphocytes.
Journal of immunological methods 1992;146(2):195-202.
1991: B Skrede; Heidi Kiil Blomhoff; Erlend Smeland; K O Wathne; Kaare R Norum; Rune Blomhoff
Retinyl esters in chylomicron remnants inhibit growth of myeloid and lymphoid leukaemic cells.
European journal of clinical investigation 1991;21(6):574-9.
1991: C Skjønsberg; Bjørn Erikstein; Erlend Smeland; S O Lie; Steinar Funderud; K Beiske; Heidi Kiil Blomhoff
Interleukin-7 differentiates a subgroup of acute lymphoblastic leukemias.
Blood 1991;77(11):2445-50.
1991: J Lømo; Erlend Smeland; Trond Stokke; Harald Holte; Steinar Funderud; Heidi Kiil Blomhoff
Differential effects of interferon-gamma and low molecular weight BCGF on growth of human B lymphocytes; interferon-gamma prolongs the increased c-MYC mRNA levels after activation.
Scandinavian journal of immunology 1991;33(4):365-73.
1991: Bjørn Erikstein; Erlend Smeland; Heidi Kiil Blomhoff; Steinar Funderud; K Prydz; W Lesslauer; T Espevik
Independent regulation of 55-kDa and 75-kDa tumor necrosis factor receptors during activation of human peripheral blood B lymphocytes.
European journal of immunology 1991;21(4):1033-7.
1991: Bjørn Naume; U Nonstad; Bjørg Steinkjer; Steinar Funderud; Erlend Smeland; Terje Espevik
Immunomagnetic isolation of NK and LAK cells.
Journal of immunological methods 1991;136(1):1-9.
1991: Bjørn Erikstein; P Schwarze; Heidi Kiil Blomhoff; Steinar Funderud; Trond Stokke; Erlend Smeland
Use of size fractionation of in vitro-activated human B lymphocytes for studies of cell cycle-dependent growth regulation.
Scandinavian journal of immunology 1991;33(1):51-60.
1990: Ivan Stamenkovic; H C Asheim; A Deggerdal; Heidi Kiil Blomhoff; Erlend Smeland; Steinar Funderud
The B cell antigen CD75 is a cell surface sialytransferase.
The Journal of experimental medicine 1990;172(2):641-3.
1990: C Skjønsberg; H Kiil Blomhoff; Gustav Gaudernack; Steinar Funderud; K Beiske; Erlend Smeland
Immunological typing of acute leukaemias by rosetting with immunomagnetic beads: comparison with immunofluorescence staining.
Scandinavian journal of immunology 1990;31(5):567-73.
1990: Erlend Smeland; Harald Holte; H Kiil Blomhoff; H C Asheim; Trond Stokke; P Torjesen; Steinar Funderud
Inhibition of polyphosphoinositide breakdown and c-myc induction accompanying inhibition of human B-cell activation by two monoclonal antibodies against the leucocyte common antigen (CD45).
Scandinavian journal of immunology 1990;31(5):583-91.
1990: H Schøyen; Jens-Gustav Iversen; Erlend Smeland; R Heikkilä
A transient acidification linked to intracellular Ca2+ in anti-mu-stimulated human B-lymphocytes.
Acta physiologica Scandinavica 1990;138(2):221-7.
1990: J Helgestad; Rolf D Pettersen; I Storm-Mathisen; L Schjerven; K Ulrich; Erlend Smeland; T Egeland; D Sørskaard; A Brøgger; T Hovig
Characterization of a new malignant human T-cell line (PFI-285) sensitive to ascorbic acid.
European journal of haematology 1990;44(1):9-17.
1990: Steinar Funderud; Bjørn Erikstein; H C Asheim; Kjell Nustad; Trond Stokke; Heidi Kiil Blomhoff; Harald Holte; Erlend Smeland
Functional properties of CD19+ B lymphocytes positively selected from buffy coats by immunomagnetic separation.
European journal of immunology 1990;20(1):201-6.
1989: Harald Holte; C de Lange Davies; K Beiske; Trond Stokke; P F Marton; Erlend Smeland; J Høie; Stein Kvaløy
Ki67 and 4F2 antigen expression as well as DNA synthesis predict survival at relapse/tumour progression in low-grade B-cell lymphoma.
International journal of cancer. Journal international du cancer 1989;44(6):975-80.
1989: Erlend Smeland; T Godal
[The 1989 Nobel Prize in physiology and medicine].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 1989;109(34-36):3541-2.
1989: A L Børresen; A Brøgger; P Møller; Erlend Smeland
[Gene technology in the prevention of cancer].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 1989;109(33):3430-4.
1989: Erlend Smeland; Heidi Kiil Blomhoff; Steinar Funderud; M R Shalaby; T Espevik
Interleukin 4 induces selective production of interleukin 6 from normal human B lymphocytes.
The Journal of experimental medicine 1989;170(4):1463-8.
1989: Harald Holte; Heidi Kiil Blomhoff; K Beiske; Steinar Funderud; P Torjesen; G Gaudernack; Trond Stokke; Erlend Smeland
Intracellular events associated with inhibition of B cell activation by monoclonal antibodies to HLA class II antigens.
European journal of immunology 1989;19(7):1221-5.
1989: L Brinch; S A Evensen; P Stavem; Erlend Smeland
[Experiences of immunologic phenotyping in acute leukemia].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 1989;109(4):443-6.
1989: Harald Holte; T Stokke; Erlend Smeland; R Watt; Heidi Kiil Blomhoff; O Kaalhus; Rolf Ohlsson
Levels of myc protein, as analyzed by flow cytometry, correlate with cell growth potential in malignant B-cell lymphomas.
International journal of cancer. Journal international du cancer 1989;43(1):164-70.
1988: Heidi Kiil Blomhoff; Rune Blomhoff; T Stokke; C deLange Davies; Kristin B Andersson; Erlend Smeland; Steinar Funderud; T Godal
cAMP-mediated growth inhibition of a B-lymphoid precursor cell line Reh is associated with an early transient delay in G2/M, followed by an accumulation of cells in G1.
Journal of cellular physiology 1988;137(3):583-7.
1988: Erlend Smeland; Heidi Kiil Blomhoff; Rolf Ohlsson; C De Lange Davies; Steinar Funderud; E Boye
Transcription of protooncogenes during stimulation of normal human B lymphocytes.
European journal of immunology 1988;18(11):1847-50.
1988: K Beiske; E A Clark; Harald Holte; J A Ledbetter; Erlend Smeland; T Godal
Triggering of neoplastic B cells via surface IgM and the cell surface antigens CD20 and CDw40. Responses differ from normal blood B cells and are restricted to certain morphologic subsets.
International journal of cancer. Journal international du cancer 1988;42(4):521-8.
1988: Harald Holte; P Torjesen; Heidi Kiil Blomhoff; E Ruud; Steinar Funderud; Erlend Smeland
Cyclic AMP has the ability to influence multiple events during B cell stimulation.
European journal of immunology 1988;18(9):1359-66.
1988: K O Wathne; Kaare R Norum; Erlend Smeland; Rune Blomhoff
Retinol bound to physiological carrier molecules regulates growth and differentiation of myeloid leukemic cells.
The Journal of biological chemistry 1988;263(18):8691-5.
1988: Erlend Smeland
[Cellular oncogenes. Role in normal cell growth and activation in neoplasms].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 1988;108(16):1299-303.
1988: Erlend Smeland
[The immunoglobulin gene superfamily].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 1988;108(13):1029-32, 1004.
1987: Erlend Smeland; K Beiske; B Ek; R Watt; S Pfeifer-Ohlsson; Heidi Kiil Blomhoff; T Godal; Rolf Ohlsson
Regulation of c-myc transcription and protein expression during activation of normal human B cells.
Experimental cell research 1987;172(1):101-9.
1987: J Lømo; Harald Holte; C de Lange Davies; E Ruud; M Laukas; Erlend Smeland; T Godal; Heidi Kiil Blomhoff
Downregulation of c-myc RNA is not a prerequisite for reduced cell proliferation, but is associated with G1 arrest in B-lymphoid cell lines.
Experimental cell research 1987;172(1):84-91.
1987: Erlend Smeland; Heidi Kiil Blomhoff; Harald Holte; E Ruud; K Beiske; Steinar Funderud; T Godal; Rolf Ohlsson
Transforming growth factor type beta (TGF beta) inhibits G1 to S transition, but not activation of human B lymphocytes.
Experimental cell research 1987;171(1):213-22.
1987: Heidi Kiil Blomhoff; Erlend Smeland; K Beiske; Rune Blomhoff; E Ruud; T Bjøro; S Pfeifer-Ohlsson; R Watt; Steinar Funderud; T Godal
Cyclic AMP-mediated suppression of normal and neoplastic B cell proliferation is associated with regulation of myc and Ha-ras protooncogenes.
Journal of cellular physiology 1987;131(3):426-33.
1987: Erlend Smeland; K Beiske; Rolf Ohlsson; Harald Holte; E Ruud; Heidi Kiil Blomhoff; R Jefferis; T Godal
Activation of human B cells: alternate options for initial triggering and effects of nonmitogenic concentrations of anti-IgM antibodies on resting and activated cells.
Journal of immunology (Baltimore, Md. : 1950) 1987;138(10):3179-84.
1987: Harald Holte; C D Davies; Stein Kvaløy; Erlend Smeland; A Foss-Abrahamsen; O Kaalhus; P F Marton; T Godal
The activation-associated antigen 4F2 predicts patient survival in low-grade B-cell lymphomas.
International journal of cancer. Journal international du cancer 1987;39(5):590-4.
1987: Heidi Kiil Blomhoff; Erlend Smeland; Abu Salim Mustafa; T Godal; Rolf Ohlsson
Epstein-Barr virus mediates a switch in responsiveness to transforming growth factor, type beta, in cells of the B cell lineage.
European journal of immunology 1987;17(2):299-301.
1986: Knut Dahl-Jørgensen; O Brinchmann-Hansen; Kristian F Hanssen; T Ganes; P Kierulf; Erlend Smeland; L Sandvik; O Aagenaes
Effect of near normoglycaemia for two years on progression of early diabetic retinopathy, nephropathy, and neuropathy: the Oslo study.
British medical journal (Clinical research ed.) 1986;293(6556):1195-9.
1986: T Lea; Erlend Smeland; Steinar Funderud; Frode Vartdal; C Davies; K Beiske; J Ugelstad
Characterization of human mononuclear cells after positive selection with immunomagnetic particles.
Scandinavian journal of immunology 1986;23(4):509-19.
1986: Erlend Smeland; T Godal
IgG subclasses in lymphomas.
Monographs in allergy 1986;19():164-8.
1986: Erlend Smeland; T Godal; K Beiske; R Watt; S Pfeifer-Ohlsson; Rolf Ohlsson
Regulation of c-myc mRNA and protein levels during activation of normal human B cells.
Current topics in microbiology and immunology 1986;132():290-6.
1985: H T Andersen; Erlend Smeland; J O Owe; K Myhre
Analyses of maximum cardiopulmonary performance during exposure to acute hypoxia at simulated altitude--sea level to 5000 meters (760-404 mm Hg).
Aviation, space, and environmental medicine 1985;56(12):1192-7.
1985: Erlend Smeland; T Godal; E Ruud; K Beiske; Steinar Funderud; E A Clark; S Pfeifer-Ohlsson; Rolf Ohlsson
The specific induction of myc protooncogene expression in normal human B cells is not a sufficient event for acquisition of competence to proliferate.
Proceedings of the National Academy of Sciences of the United States of America 1985;82(18):6255-9.
1985: R Heikkilä; Jens-Gustav Iversen; Erlend Smeland; T Godal
Intracellular Ca2+ buffering potentiates an 86Rb+ permeability response in human lymphocytes.
Acta physiologica Scandinavica 1985;124(2):247-51.
1985: Erlend Smeland; Steinar Funderud; E Ruud; H Kiil Blomhoff; T Godal
Characterization of two murine monoclonal antibodies reactive with human B cells. Their use in a high-yield, high-purity method for isolation of B cells and utilization of such cells in an assay for B-cell stimulating factor.
Scandinavian journal of immunology 1985;21(3):205-14.
1985: T Godal; C Davies; Erlend Smeland; R Heikkilä; Steinar Funderud; H B Steen; K Hildrum
Antibodies to surface IgM and IgD increase the expression of various class II antigens on human B cells.
European journal of immunology 1985;15(2):173-7.
1984: Erlend Smeland; R Jefferis; T Godal
Surface IgG subclasses in human B cell lymphomas as revealed by monoclonal antibodies.
Clinical and experimental immunology 1984;57(1):163-70.
1984: Erlend Smeland; J O Owe; H T Andersen
Modification of the 'dividing bradycardia' by hypoxia or exercise.
Respiration physiology 1984;56(2):245-51.
1984: T Bjøro; Per Ivar Gaarder; Erlend Smeland; L Kornstad
Thyroid antibodies in blood donors: prevalence and clinical significance.
Acta endocrinologica 1984;105(3):324-9.